Loading...
Experimental Pharmacological Agents for the Treatment of Primary Biliary Cholangitis
The standard therapy for primary biliary cholangitis (PBC) is ursodeoxycholic acid (UDCA) which has shown to improve hepatic biochemistry, delay histological progression and improve transplant-free survival. Approximately 30–40% of patients do not respond or are intolerant to UDCA. Obeticholic acid,...
Na minha lista:
| Udgivet i: | J Exp Pharmacol |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7751712/ https://ncbi.nlm.nih.gov/pubmed/33364858 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JEP.S267375 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|